Metformin Vitabalans

Metformin, the active ingredient in Metformin Vitabalans, is a biguanide presented as an oral tablet for oral use. It is used to lower blood glucose levels in adults with type 2 diabetes mellitus and may be prescribed as part of a comprehensive diabetes management plan.

GNH USA supplies Metformin Vitabalans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Vitabalans belongs to the biguanide class and is indicated for conditions related to impaired glucose regulation.

- Type 2 diabetes mellitus: improves glycaemic control and reduces HbA1c levels. - Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes when combined with lifestyle measures. - Polycystic ovary syndrome (off‑label): may improve insulin resistance and menstrual regularity.

Metformin Vitabalans may be associated with a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhoea: frequent loose stools, often transient. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: may develop with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycaemia: uncommon when used alone, more likely with concomitant insulin. - Pancreatitis: rare inflammatory condition of the pancreas.

When prescribing Metformin Vitabalans, several safety considerations should be observed.

- Renal function assessment: avoid use in severe renal impairment (eGFR <30 mL/min/1.73 m²). - Hepatic disease monitoring: use with caution in patients with liver dysfunction. - Lactic acidosis risk: discontinue before any radiographic contrast procedures. - Alcohol consumption: limit intake to reduce acidosis risk. - Vitamin B12 monitoring: periodic testing recommended during long‑term therapy. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Metformin Vitabalans can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate lactic acidosis; discontinue metformin before and after imaging. - Cimetidine: can increase metformin plasma concentrations. - Alcohol excess: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function and electrolytes. - Warfarin: may require INR monitoring. - Oral contraceptives: may modestly increase metformin levels.